- High-quality companies which generate impressive and consistent returns on capital employed ("ROCE") should always be on your radar.
- Sherwin-Williams has once again demonstrated its true powers during the Covid-19 pandemic.
- With a fair value estimate of roughly $850 for FY2021, shares provide attractive upside potential of 15.5%. We initiate "BUY" rating.
- The deleveraging process after completing the Valspar acquisition in FY2017 remains well on track and should allow for a continuation of more aggressive share repurchase programs.
For further details see:
Sherwin-Williams: Take An Annualized Return Of 15+% In 2021 And Beyond